- Home
- GSIW vs PRPH Comparison
GSIW vs PRPH Comparison
Compare GSIW & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- PRPH
- Stock Information
- Founded
- GSIW 2016
- PRPH 1989
- Country
- GSIW Hong Kong
- PRPH United States
- Employees
- GSIW N/A
- PRPH N/A
- Industry
- GSIW
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- GSIW
- PRPH Health Care
- Exchange
- GSIW Nasdaq
- PRPH Nasdaq
- Market Cap
- GSIW 8.3M
- PRPH 10.7M
- IPO Year
- GSIW 2023
- PRPH 1997
- Fundamental
- Price
- GSIW $0.44
- PRPH $0.30
- Analyst Decision
- GSIW
- PRPH
- Analyst Count
- GSIW 0
- PRPH 0
- Target Price
- GSIW N/A
- PRPH N/A
- AVG Volume (30 Days)
- GSIW 45.1K
- PRPH 741.6K
- Earning Date
- GSIW 12-31-2024
- PRPH 05-16-2025
- Dividend Yield
- GSIW N/A
- PRPH N/A
- EPS Growth
- GSIW N/A
- PRPH N/A
- EPS
- GSIW N/A
- PRPH N/A
- Revenue
- GSIW $1,313,795.00
- PRPH $6,770,000.00
- Revenue This Year
- GSIW N/A
- PRPH $221.82
- Revenue Next Year
- GSIW N/A
- PRPH N/A
- P/E Ratio
- GSIW N/A
- PRPH N/A
- Revenue Growth
- GSIW N/A
- PRPH N/A
- 52 Week Low
- GSIW $0.35
- PRPH $0.22
- 52 Week High
- GSIW $12.30
- PRPH $5.62
- Technical
- Relative Strength Index (RSI)
- GSIW 52.90
- PRPH 45.72
- Support Level
- GSIW $0.38
- PRPH $0.30
- Resistance Level
- GSIW $0.44
- PRPH $0.38
- Average True Range (ATR)
- GSIW 0.03
- PRPH 0.04
- MACD
- GSIW 0.01
- PRPH -0.00
- Stochastic Oscillator
- GSIW 85.11
- PRPH 30.91
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.